Order Article Reprints

Takeda T, Yamada T, Tanimura K, Nakano T, Ishida M, Tachibana Y, Shiotsu S, Horiuchi S, Hibino M, Okada A, et al. Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. Diagnostics. 2021; 11(12):2170. https://doi.org/10.3390/diagnostics11122170

Takeda, Takayuki, Tadaaki Yamada, Keiko Tanimura, Takayuki Nakano, Masaki Ishida, Yusuke Tachibana, Shinsuke Shiotsu, Shigeto Horiuchi, Makoto Hibino, Asuka Okada, and et al. 2021. "Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib" Diagnostics 11, no. 12: 2170. https://doi.org/10.3390/diagnostics11122170

Takeda, T., Yamada, T., Tanimura, K., Nakano, T., Ishida, M., Tachibana, Y., Shiotsu, S., Horiuchi, S., Hibino, M., Okada, A., Chihara, Y., & Takayama, K. (2021). Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib. Diagnostics, 11(12), 2170. https://doi.org/10.3390/diagnostics11122170